StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.42+0.03 (+2.16%)

Close on Nov 16, 2026Market cap $36.07MP/E –Yield –

Serina Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Serina Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$21.14M. For fiscal 2025 it was -$17.96M. The highest annual figure on record is -$2.48M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.96M–
FY2024Dec 31, 2024-$17.14M–
FY2023Dec 31, 2023-$2.48M–
FY2022Dec 31, 2022-$5.94M–
FY2021Dec 31, 2021-$7.86M–
FY2020Dec 31, 2020-$7.82M–
FY2019Dec 31, 2019-$10.16M–
FY2018Dec 31, 2018-$8.00M–
FY2017Dec 31, 2017-$6.29M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.68M–
Q1 FY2026Mar 31, 2026-$4.57M–
Q4 FY2025Dec 31, 2025-$6.03M–
Q3 FY2025Sep 30, 2025-$3.85M–
Q2 FY2025Jun 30, 2025-$3.75M–
Q1 FY2025Mar 31, 2025-$4.32M–
Q4 FY2024Dec 31, 2024-$4.59M-3892.6%
Q3 FY2024Sep 30, 2024-$2.96M–
Q2 FY2024Jun 30, 2024-$8.01M–
Q1 FY2024Mar 31, 2024-$1.58M–
Q4 FY2023Dec 31, 2023$121.00K–
Q3 FY2023Sep 30, 2023-$1.02M–
Q2 FY2023Jun 30, 2023-$864.00K–
Q1 FY2023Mar 31, 2023-$709.00K–
Q4 FY2022Dec 31, 2022-$1.32M–
Q3 FY2022Sep 30, 2022-$1.24M–
Q2 FY2022Jun 30, 2022-$1.75M–
Q1 FY2022Mar 31, 2022-$1.64M–
Q4 FY2021Dec 31, 2021-$1.65M–
Q3 FY2021Sep 30, 2021-$1.88M–
Q2 FY2021Jun 30, 2021-$1.69M–
Q1 FY2021Mar 31, 2021-$2.63M–
Q4 FY2020Dec 31, 2020-$1.62M–
Q3 FY2020Sep 30, 2020-$1.89M–
Q2 FY2020Jun 30, 2020-$2.24M–
Q1 FY2020Mar 31, 2020-$2.06M–
Q4 FY2019Dec 31, 2019-$2.41M–
Q3 FY2019Sep 30, 2019-$2.37M–
Q2 FY2019Jun 30, 2019-$2.76M–
Q1 FY2019Mar 31, 2019-$2.62M–
Q4 FY2018Dec 31, 2018-$2.05M–
Q3 FY2018Sep 30, 2018-$1.78M–
Q2 FY2018Jun 30, 2018-$2.16M–
Q1 FY2018Mar 31, 2018-$2.01M–

More Serina Therapeutics figures

See a number that looks wrong?